VNDA

Vanda Pharmaceuticals Inc.

Biotechnology · Biotechnology

$246.73 sample

+0.29 (+0.12%) 1D

Market cap

$969.6B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-01

Alerts

8

Price$246.73 +0.16% 3M daily closessample

251.98231.93

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: General Counsel
Oct 06INSInsider buy: Director
Oct 01SECForm 144 filed
Sep 22INSInsider buy: Director
Sep 16INSInsider sell: Chief Executive Officer
Sep 10INSInsider buy: EVP, Operations
Sep 02INSInsider sell: Chief Financial Officer
Aug 28INSInsider sell: Director

Sign up to see the real VNDA record →

Company facts

SEC EDGAR registration

Name: Vanda Pharmaceuticals Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -37sample, -100 to +100
Reporting currency: USD

Who is positioning in VNDA

sample

Insiders: 19 insider transactions over 90 days, net selling, $273.0M
Congress: 5 members traded over 90 days
Institutions · 13F: 44 funds hold $5.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$63.3B +19.0% y/y

Q4 2024Q3 2026

Inventory$39.0B +14.2% y/y

Q4 2024Q3 2026

Accounts receivable$27.6B +11.1% y/y

Q4 2024Q3 2026

Total debt$72.7B +7.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $498.4B -9.7% 3M
Sample peer B: $779.1B -8.5% 3M
Sample peer C: $895.1B +15.3% 3M
Sample peer D: $390.0B -8.2% 3M
Sample peer E: $872.9B -1.2% 3M